European Companies Search Engine
Member of the Executive Board: Klaus D. Englmaier, Andreas Niedermaier, Jan Ulli Seibel · Address · Capital: €100.6M · Name: AlzChem Group AG · Proxy policy · Corporate Purpose Hrb16 Oct 2017 German Trade Register Announcements, Germany (02/10/2017)
Overview
Text
HRB 2000 NO: AlzChem Group AG,
Norderstedt, Dr.-Albert-Frank-Str. 32, 83308 Trostberg
. Company name: AlzChem Group AG; Registered office of the company: Business address: Dr.-
Unnamed street ??, 83308 Trostberg, Germany
; The aicable is the development, manufacture, trade and distribution of chemical products of all kinds, as well as the supply of services in the commercial and industrial fields. Acquisition, management and sale of shareholdings in other companies and real estate. Capital: EUR 101,763,355; Representation: The company is represented by two members of the Board of Management or by a member of the Board of Management in association with an authorized representative. Board of Directors: 3rd Englmaier, Klaus Dieter, *??.??.????, Truchtlaching; with the power to represent the Company with another member of the Board of Management or an authorized representative with the power to enter into legal transactions as a representative of third parties; Board of Directors: 4th Niedermaier, Andreas, *??.??.????, Gigling; with the power to represent the Company with another member of the Board of Management or an authorized representative with the power to enter into legal transactions as a representative of third parties; Board of Directors: 5 th. Seibel, Jan Ulli, *??.??.????, Truchtlaching; with the power to represent the company alone with the power to enter into legal transactions as a representative of third parties; Legal form: By resolution of the Annual General Meeting of August 4, 2017, an authorized capital has been created and the Articles of Association have been amended in the course of a complete recast with regard to the company, subject-matter and general representation arrangements. The Annual General Meeting on August 4, 2017 decided to increase the share capital to EUR 100,633,339. The capital increase has been carried out. The Annual General Meeting on August 4, 2017 decided to further increase the share capital by up to EUR 38,246,661. The capital increase was carried out in the amount of EUR 1,130,016. By resolution of the Supervisory Board of September 26, 2017, the Articles of Association have been amended in Section 4 (height and division of the share capital). Legal relations: On September 26, 2017, the company concluded a re-establishment agreement with LIVIA Corporate Development SE, HDI Preminger GmbH, Edelweiss Holding GmbH and Mr. Jan Ulli Seibel, which was approved by the Annual General Meeting by resolution of August 4, 2017. By resolution of the Annual General Meeting of August 4, 2017, the Management Board is authorized to increase the share capital by a total of up to EUR 10,063,333 by July 31, 2022 against cash and/or non-cash deposits, one-off or several times, with the approval of the Supervisory Board. Shareholders' subscription rights may be excluded. (Authorized capital 2017/I)
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Alzchem Group AG, Trostberg, Germany.